Concepedia

Risk Factors for Cefoperazone/Sulbactam-Induced Coagulation Disorder

Miao Wan, Jinlin Guo, H.-Y. Cheng, Qianqian Zhao

Infection and Drug Resistance · 2023 · 16 citations · 17 references

DOIFull text

Open access

Abstract

Tigecycline and valproic acid were not associated with CIC. Advanced age and long treatment duration are risk factors for CIC. Supplementation with vitamin K during cefoperazone/sulbactam treatment was associated with a reduced risk.

References

17

Task force on management and prevention of Acinetobacter baumannii infections in the ICU

José Garnacho‐Montero, George Dimοpoulos, Garyphallia Poulakou et al. · Intensive Care Medicine · 2015 · 171 citations

, , +7

N-METHYL-THIO-TETRAZOLE INHIBITION OF THE GAMMA CARBOXYLATION OF GLUTAMIC ACID: POSSIBLE MECHANISM FOR ANTIBIOTIC-ASSOCIATED HYPOPROTHROMBINAEMIA

JamesJ. Lipsky · The Lancet · 1983 · 144 citations

, , +3

Use of Hypoprothrombinemia-Inducing Cephalosporins and the Risk of Hemorrhagic Events: A Nationwide Nested Case-Control Study

Li‐Ju Chen, Fei‐Yuan Hsiao, Li‐Jiuan Shen et al. · PLoS ONE · 2016 · 52 citations · Full text

Risk Factors for Tigecycline-Associated Hypofibrinogenemia

Jia Liu, Yingying Yan, Fan Zhang · Therapeutics and Clinical Risk Management · 2021 · 38 citations · Full text

Detection and characterization of tigecycline heteroresistance in <i>E. cloacae</i> : clinical and microbiological findings

Hang Liu, Xiaojiong Jia, Hua Zou et al. · Emerging Microbes & Infections · 2019 · 32 citations · Full text

, , +21